Atlas Biomed Revenue and Competitors

London, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Atlas Biomed's estimated annual revenue is currently $5.1M per year.(i)
  • Atlas Biomed's estimated revenue per employee is $155,000

Employee Data

  • Atlas Biomed has 33 Employees.(i)
  • Atlas Biomed grew their employee count by -47% last year.

Atlas Biomed's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Company Director, US Coordinating ManagerReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Customer Service Operations ManagerReveal Email/Phone
5
Business AdvisorReveal Email/Phone
6
B2B Business Development DirectorReveal Email/Phone
7
Group General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M902%$277MN/A
#2
$258.5M898-10%$1.1B$2.4B
Add Company

What Is Atlas Biomed?

Atlas Biomed is a personalized health company applying the latest genetic technologies to inspire consumers into a positive lifestyle change, and lead them into a healthier future.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

-47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Atlas Biomed News

2022-04-17 - The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029

... DayTwo (US), BIOHM (US), Atlas Biomed (UK), Bione (India), Luxia Scientific (France), Sun Genomics (US), and Metabiomics (US).

2022-04-06 - Direct to Consumer Microbiome Analyzing Market ...

Atlas Biomed Group Limited. Viome, Inc. 23andMe, Inc uBiome. Carbiotix AB BIOMES NGS GmbH. Quantbiome, Inc. TFTAK. The growth in number...

2022-03-30 - Human Microbiome-based Gut Health Test and Nutrition ...

... Hyperbiotics, Everidis, Floraster, Enfamil, Culturelle, Biogaia, Viome, Atlas Biomed, Nouri, Bayer Consumer Health, Clasado Biosciences,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M33-33%N/A
#2
$3.8M330%$6M
#3
$7.1M33-8%N/A
#4
$3.2M33-3%N/A
#5
$3.8M336%N/A